Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
- Brazil's Bolsonaro, Lula spar in first debate as personal attacks fly
- Cerebras Systems falls as TD Cowen cuts price target
- Nasdaq climbs as chip and AI-linked stocks bounce back
- Glass House Brands posts Q3 revenue of $56.8M, board member exits
- Moderna shares rise ahead of cancer vaccine trial results
SEC Won't Comment on Speculation of Valeant Pharmaceuticals (VRX) Probe
October 22, 2015 3:43 PM EDTThe SEC would not comment to StreetInsider.com on speculation that it is investigating Valeant Pharmaceuticals (NYSE: VRX) amid allegations related to its relationship with Philidor and R&O, accounting practices, and channel stuffing. "As per our policy, we can not confirm or... More
Valeant Pharma (VRX) to Hold Investor Conference Call on October 26
October 22, 2015 2:39 PM EDTValeant Pharma (NYSE: VRX) today announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect... More
Valeant Pharma (VRX) Will Hold Investor Conf. Call on Oct. 26th
October 22, 2015 2:39 PM EDTValeant Pharma (NYSE: VRX) announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect interpretations of... More



